Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study.

Fenoll A, Ardanuy C, Liñares J, Cercenado E, Marco F, Fleites A, Rodríguez-Mayo M, López-Hontangas JL, Palop B, Aller AI, Buendía B, Méndez C, Cifuentes I; ODIN Study Group.

Vaccine. 2018 Dec 18;36(52):7993-8000. doi: 10.1016/j.vaccine.2018.10.098. Epub 2018 Nov 16.

PMID:
30449634
2.

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.

Càmara J, Marimón JM, Cercenado E, Larrosa N, Quesada MD, Fontanals D, Cubero M, Pérez-Trallero E, Fenoll A, Liñares J, Ardanuy C.

PLoS One. 2017 Apr 6;12(4):e0175224. doi: 10.1371/journal.pone.0175224. eCollection 2017.

3.

Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis.

Corsini B, Aguinagalde L, Ruiz S, Domenech M, Antequera ML, Fenoll A, García P, García E, Yuste J.

Vaccine. 2016 Dec 7;34(50):6148-6157. doi: 10.1016/j.vaccine.2016.11.001. Epub 2016 Nov 10.

PMID:
27840016
4.

Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response.

Aguinagalde L, Corsini B, Domenech A, Domenech M, Cámara J, Ardanuy C, García E, Liñares J, Fenoll A, Yuste J.

PLoS One. 2015 Sep 14;10(9):e0137565. doi: 10.1371/journal.pone.0137565. eCollection 2015.

5.
6.

Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro.

Domenech M, Damián D, Ardanuy C, Liñares J, Fenoll A, García E.

PLoS One. 2015 Apr 30;10(4):e0125636. doi: 10.1371/journal.pone.0125636. eCollection 2015.

7.

Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain.

Ardanuy C, de la Campa AG, García E, Fenoll A, Calatayud L, Cercenado E, Pérez-Trallero E, Bouza E, Liñares J.

Emerg Infect Dis. 2014 Nov;20(11):1848-56. doi: 10.3201/eid2011.131215.

8.

Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.

Domenech A, Tirado-Vélez JM, Fenoll A, Ardanuy C, Yuste J, Liñares J, de la Campa AG.

Antimicrob Agents Chemother. 2014;58(4):2393-9. doi: 10.1128/AAC.02669-13. Epub 2014 Feb 10.

9.

Evolution and genetic diversity of the Spain23F-ST81 clone causing adult invasive pneumococcal disease in Barcelona (1990-2012).

Domenech A, Ardanuy C, Grau I, Calatayud L, Pallares R, Fenoll A, Brueggemann AB, Liñares J.

J Antimicrob Chemother. 2014 Apr;69(4):924-31. doi: 10.1093/jac/dkt473. Epub 2013 Dec 8.

10.

Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).

Rolo D, Fenoll A, Fontanals D, Larrosa N, Giménez M, Grau I, Pallarés R, Liñares J, Ardanuy C; Serotype 5 Study Group.

J Clin Microbiol. 2013 Nov;51(11):3585-90. doi: 10.1128/JCM.01538-13. Epub 2013 Aug 21.

11.

Disease isolates of Streptococcus pseudopneumoniae and non-typeable S. pneumoniae presumptively identified as atypical S. pneumoniae in Spain.

Rolo D, S Simões A, Domenech A, Fenoll A, Liñares J, de Lencastre H, Ardanuy C, Sá-Leão R.

PLoS One. 2013;8(2):e57047. doi: 10.1371/journal.pone.0057047. Epub 2013 Feb 21.

12.

Comparative in vitro activity of common antibiotics and relationship with changes in Streptococcus pneumoniae serotypes causing otitis in children prior to and 10 years after introduction of conjugate vaccines in Spain.

Fenoll A, Aguilar L, Giménez MJ, Vicioso MD, Robledo O, Granizo JJ, Coronel P.

Int J Antimicrob Agents. 2012 Oct;40(4):376-7. doi: 10.1016/j.ijantimicag.2012.06.002. Epub 2012 Jul 20. No abstract available.

PMID:
22819148
13.

Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain.

Fenoll A, Aguilar L, Giménez MJ, Vicioso MD, Robledo O, Granizo JJ, Coronel P.

Int J Antimicrob Agents. 2012 Jul;40(1):18-23. doi: 10.1016/j.ijantimicag.2012.03.001. Epub 2012 May 11.

PMID:
22578763
14.
15.

[Epidemiology of nasopharyngeal carriage of Streptococcus pneumoniae in children < 6 years old in Seville].

Obando I, Sánchez-Tatay D, Molinos-Quintana A, Delgado-Pecellin I, Porras A, Morillo-Gutiérrez B, Fenoll A, Lirola MJ.

Enferm Infecc Microbiol Clin. 2011 Oct;29(8):581-6. doi: 10.1016/j.eimc.2011.05.010. Epub 2011 Aug 6. Spanish.

PMID:
21821320
16.

Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage.

Rolo D, Fenoll A, Ardanuy C, Calatayud L, Cubero M, de la Campa AG, Liñares J.

J Antimicrob Chemother. 2011 Aug;66(8):1712-8. doi: 10.1093/jac/dkr193. Epub 2011 May 31.

PMID:
21628304
17.

Characterization of invasive Pneumococci of serogroup 6 from adults in Barcelona, Spain, in 1994 to 2008.

Rolo D, Ardanuy C, Calatayud L, Pallares R, Grau I, García E, Fenoll A, Martín R, Liñares J.

J Clin Microbiol. 2011 Jun;49(6):2328-30. doi: 10.1128/JCM.02545-10. Epub 2011 Mar 30.

18.

Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.

Tarragó D, Aguilar L, García R, Gimenez MJ, Granizo JJ, Fenoll A.

Antimicrob Agents Chemother. 2011 May;55(5):2297-302. doi: 10.1128/AAC.01494-10. Epub 2011 Feb 22.

19.

Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008.

Fenoll A, Aguilar L, Vicioso MD, Gimenez MJ, Robledo O, Granizo JJ, Mendez C.

Antimicrob Agents Chemother. 2010 Dec;54(12):5387-90. doi: 10.1128/AAC.00217-10. Epub 2010 Oct 4.

20.

Pneumococcal serotypes in children in 4 European countries.

Hanquet G, Kissling E, Fenoll A, George R, Lepoutre A, Lernout T, Tarragó D, Varon E, Verhaegen J.

Emerg Infect Dis. 2010 Sep;16(9):1428-39. doi: 10.3201/eid1609.100102.

21.

Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.

Fenoll A, Aguilar L, Giménez MJ, Vicioso MD, Robledo O, Granizo JJ, Coronel P.

Antimicrob Agents Chemother. 2010 Jun;54(6):2696-8. doi: 10.1128/AAC.01594-09. Epub 2010 Mar 22.

22.

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.

Liñares J, Ardanuy C, Pallares R, Fenoll A.

Clin Microbiol Infect. 2010 May;16(5):402-10. doi: 10.1111/j.1469-0691.2010.03182.x. Epub 2010 Feb 2. Review.

23.

High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000-07).

de la Pedrosa EG, Baquero F, Loza E, Nadal-Serrano JM, Fenoll A, Del Campo R, Cantón R.

J Antimicrob Chemother. 2009 Dec;64(6):1165-9. doi: 10.1093/jac/dkp364. Epub 2009 Oct 16.

PMID:
19837717
24.

Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine.

Fenoll A, Giménez MJ, Vicioso MD, Granizo JJ, Robledo O, Aguilar L.

J Antimicrob Chemother. 2009 Dec;64(6):1338-40. doi: 10.1093/jac/dkp376. Epub 2009 Oct 14. No abstract available.

PMID:
19828490
25.

Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.

Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J.

J Antimicrob Chemother. 2009 Sep;64(3):507-10. doi: 10.1093/jac/dkp210. Epub 2009 Jun 17.

PMID:
19535383
26.

Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.

de la Campa AG, Ardanuy C, Balsalobre L, Pérez-Trallero E, Marimón JM, Fenoll A, Liñares J.

Emerg Infect Dis. 2009 Jun;15(6):905-11. doi: 10.3201/eid1506.080684.

27.

Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarragó D.

J Clin Microbiol. 2009 Apr;47(4):1012-20. doi: 10.1128/JCM.01454-08. Epub 2009 Feb 18.

28.

[Evaluation of a latex agglutination test for serotyping Streptococcus pneumoniae].

Sanz JC, Wilhelmi I, Méndez N, Fenoll A.

Enferm Infecc Microbiol Clin. 2008 Oct;26(8):531-3. Spanish. No abstract available.

PMID:
19094870
29.

Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine.

Casado-Flores J, Rodrigo C, Arístegui J, Martínón JM, Fenoll A, Mendez C.

Pediatr Infect Dis J. 2008 Nov;27(11):1020-2. doi: 10.1097/INF.0b013e31817bd2dc.

PMID:
18845983
30.

Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR.

Tarragó D, Fenoll A, Sánchez-Tatay D, Arroyo LA, Muñoz-Almagro C, Esteva C, Hausdorff WP, Casal J, Obando I.

Clin Microbiol Infect. 2008 Sep;14(9):828-34. doi: 10.1111/j.1469-0691.2008.02028.x.

31.

Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.

J Antimicrob Chemother. 2008 Dec;62(6):1430-3. doi: 10.1093/jac/dkn413. Epub 2008 Sep 26.

PMID:
18819966
32.

Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.

Soriano F, Cafini F, Aguilar L, Tarragó D, Alou L, Giménez MJ, Gracia M, Ponte MC, Leu D, Pana M, Letowska I, Fenoll A.

J Antimicrob Chemother. 2008 Dec;62(6):1234-40. doi: 10.1093/jac/dkn392. Epub 2008 Sep 16.

PMID:
18799472
33.

Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children.

Sánchez-Tatay D, Arroyo LA, Tarragó D, Lirola MJ, Porras A, Fenoll A, Hausdorff WP, Brueggemann AB, Obando I.

Clin Microbiol Infect. 2008 Aug;14(8):797-801. doi: 10.1111/j.1469-0691.2008.02025.x.

34.

In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.

Fenoll A, Aguilar L, Robledo O, Giménez MJ, Granizo JJ, Biek D, Tarragó D.

Antimicrob Agents Chemother. 2008 Nov;52(11):4209-10. doi: 10.1128/AAC.00712-08. Epub 2008 Aug 25. No abstract available.

35.

In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.

Fenoll A, Aguilar L, Robledo O, Giménez MJ, Granizo JJ, Biek D, Tarragó D.

J Antimicrob Chemother. 2008 Nov;62(5):1156-8. doi: 10.1093/jac/dkn314. Epub 2008 Jul 30. No abstract available.

PMID:
18667449
36.

High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation.

Sevillano D, Aguilar L, Alou L, Giménez MJ, González N, Torrico M, Cafini F, Fenoll A, Coronel P, Prieto J.

PLoS One. 2008 Jul 23;3(7):e2717. doi: 10.1371/journal.pone.0002717.

37.

In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.

Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Gimeno M, Coronel P.

J Chemother. 2008 Apr;20(2):175-9.

PMID:
18467242
38.

Decrease in bacterial load versus resistance selection of pneumococcal subpopulations by beta-lactam physiological concentrations over time: an in vitro pharmacodynamic simulation.

Cafini F, Aguilar L, Sevillano D, Giménez MJ, Alou L, Fenoll A, Echevarría O, Torrico M, González N, Coronel P, Prieto J.

Microb Drug Resist. 2008 Mar;14(1):13-21. doi: 10.1089/mdr.2008.0783.

PMID:
18346008
39.

Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.

Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Martín-Herrero JE.

Eur J Clin Microbiol Infect Dis. 2008 Jan;27(1):75-80. Epub 2007 Oct 18.

PMID:
17943330
40.

Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.

Calatayud L, Ardanuy C, Cercenado E, Fenoll A, Bouza E, Pallares R, Martín R, Liñares J.

Antimicrob Agents Chemother. 2007 Sep;51(9):3240-6. Epub 2007 Jul 2.

41.

Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.

Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P.

J Antimicrob Chemother. 2007 Aug;60(2):323-7. Epub 2007 Jun 11.

PMID:
17562681
42.

Microbiologic workload and clinical significance of Streptococcus pneumoniae isolated during one week in Spain.

Bouza E, Arenas C, Cercenado E, Cuevas O, Vicioso D, Fenoll A.

Microb Drug Resist. 2007 Spring;13(1):52-61.

PMID:
17536934
43.

Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones.

Fenoll A, Giménez MJ, Robledo O, Coronel P, Gimeno M, Casal J, Aguilar L.

Int J Antimicrob Agents. 2007 Feb;29(2):224-6. Epub 2006 Dec 18. No abstract available.

PMID:
17175141
44.

Very high resistance to amoxicillin in Streptococcus pneumoniae: an epidemiological fact or a technical issue?

Camacho MT, Casal J, Aguilar L, Gimenez MJ, Fenoll A.

J Chemother. 2006 Jun;18(3):303-6.

PMID:
17129842
45.

Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptible.

Balsalobre L, Hernández-Madrid A, Llull D, Martín-Galiano AJ, García E, Fenoll A, de la Campa AG.

J Clin Microbiol. 2006 Nov;44(11):4163-71. Epub 2006 Sep 13.

46.
47.

Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: a pharmacodynamic in vitro model approach to selection of resistant populations.

Sevillano D, Aguilar L, Alou L, Giménez MJ, Echevarría O, Cafini F, Valero E, Fenoll A, Prieto J.

J Antimicrob Chemother. 2006 Oct;58(4):794-801. Epub 2006 Jul 30.

PMID:
16880173
48.

[Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].

Fenoll A, Robledo O, Lerma M, Giménez MJ, Cebrián L, Casal J, Aguilar L, Gómez-Lus ML.

Rev Esp Quimioter. 2006 Mar;19(1):39-44. Spanish.

49.

Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain.

del Campo R, Cafini F, Morosini MI, Fenoll A, Liñares J, Alou L, Sevillano D, Cantón R, Prieto J, Baquero F; Spanish Pneumococcal Network (G3/103).

J Antimicrob Chemother. 2006 May;57(5):983-6. Epub 2006 Mar 13.

PMID:
16533824
50.

Molecular epidemiology and variants of the multidrug-resistant Streptococcus pneumoniae Spain14-5 international clone among Spanish clinical isolates.

Marimón JM, Pérez-Trallero E, Ercibengoa M, Gonzalez A, Fenoll A; Spanish Pneumococcal Infection Study Network (G03/103).

J Antimicrob Chemother. 2006 Apr;57(4):654-60. Epub 2006 Feb 16.

PMID:
16484341

Supplemental Content

Loading ...
Support Center